Rowasa

Rowasa (mesalamine) is an aminosalicylate anti-inflammatory drug. It is administered rectally and works locally in the lower intestine and rectum to reduce inflammation, tissue damage, and diarrhea associated with ulcerative colitis.

Dosage by Body Weight

The usual adult dosage of Rowasa rectal suspension enema is one rectal instillation (4 grams in 60 mL) once a day, preferably at bedtime, and retained for approximately 8 hours.

  1. Body Weight
    Below 5 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  2. Body Weight
    5-7 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  3. Body Weight
    8-10 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  4. Body Weight
    11-15 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  5. Body Weight
    16-20 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.

Formulation

Rectal SuspensionEnema

Purpose

Treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis, or proctitis

Generic Name

Mesalamine

Scheduled Drug

No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.

Alternatives

CanasaSfrowasaPentasaLialdaAprisoDelzicol

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.